Saturday 20 April 2019 ,
Saturday 20 April 2019 ,
Latest News
  • AL govt’s popularity increases: PM
  • Nusrat murder: Sonagazi AL chief Ruhul Amin held
  • Send Subir Nandi’s medical docs to Singapore for expert opinions: PM
  • Rohingyas must go back: PM
  • Motive behind Nusrat murder evident: Minister
11 February, 2019 00:00 00 AM

icddr,b ED receives ‘Prince Mahidol Award 2018’ for cholera vaccine development

icddr,b
icddr,b ED receives ‘Prince Mahidol Award 2018’ for cholera vaccine development

icddr,b’s Executive Director and noted scientist Professor John D Clemens has received the prestigious Prince Mahidol Award 2018 for his public health contribution in developing the oral cholera vaccine and its advancement worldwide.

Professor Jan R Holmgren of the University of Gothenburg, Sweden, is the co-winner of the award, which is a leading recognition for public health innovation globally and is named after Prince Mahidol of Songkla who is regarded as the ‘father of modern medicine and public health in Thailand’.

Professor Clemens and Professor Holmgren, have long been associated with icddr,b and spent over 30 years of their scientific careers creating the solution. Nominated by a jury board for the award in November last year, they were ceremonially presented in Bangkok, Thailand, last week.

Her Royal Highness Princess Maha Chakri Sirindhorn of Thailand, President of Prince Mahidol Foundation, officially handed over the award for their extraordinary contribution to the introduction of the safe, effective, affordable and internationally licensed oral cholera vaccine (OCV). icddr,b’s Deputy Executive Director Syed Monjurul Islam, Bangladesh's Ambassador to Thailand Md. Nazmul Quaunine, among other dignitaries, were present at the ceremony held at the Grand Palace in Bangkok.

The OCV was recently administered among the forcibly displaced Myanmar nationals (FDMNs) who have taken shelter in Cox’s Bazar, Bangladesh. icddr,b along with its partners pre-emptively administered a total of one million doses of OCV among the Rohingyas who have fled into Bangladesh in order to avoid persecution in neighbouring Myanmar. It is considered as the world’s second largest OCV campaign in recent history. Public health experts suggest that this might have  prevented a potential epidemic of cholera in the Rohingyas.

In the 1980s, Prof Holmgren and colleagues at the University of Gothenburg developed the first OCV Dukoral. In 1985, Prof Clemens conducted the first OCV field trial in Matlab, Bangladesh, and has shown that the vaccine is safe and effective for up to three years. The findings helped to achieve the World Health Organisation’s (WHO’s) prequalification and international licensure of the vaccine in 50 countries.

A large cholera outbreak in Haiti in 2010 awakened the public health community to the need for oral cholera vaccines to prevent outbreaks. In 2010, the WHO recommended the use of OCVs in epidemic and endemic circumstances that led to the creation of a global OCV stockpile in 2013. From then until now more than 36 million OCV doses have been dispensed from the global stockpile to control cholera in 100 campaigns across 20 countries.

icddr,b and Prof Clemens are now coordinating the transfer of the production technology to local Incepta Pharmaceuticals in order to meet the low-cost cholera vaccine demands in Bangladesh, one of the highest cholera-burden countries, and beyond.

Upon receiving the award Prof Clemens expressed his deep gratitude to icddr,b and Bangladesh and said “Bangladesh has played a very crucial role in the development of the OCV.” He adds: “The Prince Mahidol Award creates more recognition of the effectiveness of OCVs and will further our campaign to save millions of lives in resource poor settings”. He said mass scale immunisation covering at least 60 percent of a population can effectively provide protection to the entire community. “We expect OCV to be instrumental in the WHO’s roadmap to end cholera by 2030.”

The Prince Mahidol Foundation annually confers awards to individual(s) or institution(s) that have demonstrated outstanding and exemplary contributions to the advancement of the world’s medical and public health services. Each award consists of a medal, a certificate and a sum of US $100,000. Professor Clemens and Professor Holmgren are the seventh and eighth scientists associated with icddr,b to have won the award.

 

Comments

Most Viewed
Digital Edition
More story
From the Editor

From the Editor

Haemophilia, a bleeding disorder, is our cover story this week. Haemophilia is caused by a deficiency in one of the blood clotting factors. Haemophilia…
Haemophilia and World Haemophilia Day

Haemophilia and World Haemophilia Day

World Haemophilia Day is an international awareness day for haemophilia and other bleeding disorders. It is held annually on April 17, date of the birthday…
Haemophilia A: Genetic testing and what to expect

Haemophilia A: Genetic testing and what to expect

LANA BARHUM   Genetic testing for Hemophilia A is widely available and includes carrier testing, direct DNA mutation testing, linkage testing, and…
Blood disorders and its affects

Blood disorders and its affects

Blood disorders can affect any of the three main components of blood: Red blood cells, which carry oxygen to the body's tissues White blood cells,…
Bleeding tendencies in children

Bleeding tendencies in children

Rahim, a 3 year old boy hailing from Manikgonj presented in Paediatric OPD of Dhaka Shishu Hospital with his mother who complained that Rahim had fine…
10 facts on blood transfusion

10 facts on blood transfusion

Blood transfusion saves lives and improves health, but many patients requiring transfusion do not have timely access to safe blood. The need for blood…
Bruises and its treatments

Bruises and its treatments

A bruise is a common skin injury that results in a discoloration of the skin. Blood from damaged blood cells deep beneath the skin collects near the surface…
A tiny cry for help from inside the liver could lead to better treatment

A tiny cry for help from inside the liver could lead to better treatment

On a normal day, the cells of a human liver do what they do best—making key blood proteins, clearing toxins from the blood and sending their remains…
Food better than supplements for longevity

Food better than supplements for longevity

 TRISHA CALVO A new Tufts University study involving more than 27,000 Americans is the latest research to show that most supplements may not do much…
icddr,b and partners explore pathways of antibiotic use in Bangladesh and ways to intervene

icddr,b and partners explore pathways of antibiotic use in Bangladesh and ways to intervene

Recently, scientists at icddr,b in collaboration with Loughborough University, Durham University and the University of Bristol, UK have organised a dissemination…
Recurrence score may cut costs for high-risk breast cancer care

Recurrence score may cut costs for high-risk breast cancer care

Genomic recurrence score (RS) testing using a 21-gene assay is associated with decreased cancer care costs in real-world practice among certain patients…
Call to ensure universal health coverage

Call to ensure universal health coverage

Health experts called for taking necessary steps for ensuring universal health coverage across the country in the greater interest of the country. A huge…
FDA approves Dovato (dolutegravir/lamivudine) for HIV-1 infection

FDA approves Dovato (dolutegravir/lamivudine) for HIV-1 infection

ViiV Healthcare recently announced that the US Food and Drug Administration (FDA) approved Dovato, a complete, once-daily, single-tablet regimen of dolutegravir…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting